|
PPIB expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.98427949019242E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.15090167898779E-11 |
| Normal-vs-Stage2 |
2.637600E-03 |
| Normal-vs-Stage3 |
1.765930E-04 |
| Normal-vs-Stage4 |
6.558100E-03 |
| Stage1-vs-Stage2 |
4.993000E-01 |
| Stage1-vs-Stage3 |
5.799000E-01 |
| Stage1-vs-Stage4 |
9.685600E-01 |
| Stage2-vs-Stage3 |
4.033800E-01 |
| Stage2-vs-Stage4 |
6.340000E-01 |
| Stage3-vs-Stage4 |
7.989200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.74331726411037E-13 |
| Normal-vs-AfricanAmerican |
2.47010000009595E-07 |
| Normal-vs-Asian |
9.370000E-02 |
| Caucasian-vs-AfricanAmerican |
9.508200E-01 |
| Caucasian-vs-Asian |
7.939000E-01 |
| AfricanAmerican-vs-Asian |
8.537400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.79519773782999E-11 |
| Normal-vs-Female |
1.71400005299915E-10 |
| Male-vs-Female |
1.587580E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.96000000358177E-08 |
| Normal-vs-Extreme_Weight |
9.06840158521049E-11 |
| Normal-vs-Obese |
6.66730000098426E-08 |
| Normal-vs-Extreme_Obese |
3.842100E-02 |
| Normal_Weight-vs-Extreme_Weight |
3.467600E-01 |
| Normal_Weight-vs-Obese |
3.992200E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.078400E-01 |
| Extreme_Weight-vs-Obese |
9.390600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
2.964000E-01 |
| Obese-vs-Extreme_Obese |
4.154800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.098900E-03 |
| Normal-vs-Age(41-60Yrs) |
4.53403981026668E-12 |
| Normal-vs-Age(61-80Yrs) |
5.86359849563678E-11 |
| Normal-vs-Age(81-100Yrs) |
6.956000E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.267200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.939400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.336000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.582000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.794000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.547400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.76365605347928E-14 |
| Normal-VS-Type2 PRCC |
7.569700E-04 |
| Normal-VS-KIRP CIMP |
3.138500E-02 |
| Normal-VS-Unclassified PRCC |
2.13920000002865E-06 |
| Type1 PRCC-VS-Type2 PRCC |
1.449450E-04 |
| Type1 PRCC-VS-KIRP CIMP |
9.413800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
8.159400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.188970E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
9.480400E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
9.625600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.39990000094892E-08 |
| Normal-vs-N1 |
7.995300E-04 |
| Normal-vs-N2 |
9.187700E-02 |
| N0-vs-N1 |
8.588400E-01 |
| N0-vs-N2 |
5.630400E-01 |
| N1-vs-N2 |
5.787000E-01 |
|
|
